<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period</h1>
    <p class="timestamp">Published: 2018-01-26 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of November 29, 2017. In the notice of availability, FDA requested comments on draft guidance for industry and FDA staff entitled "Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments (CLIA) Waiver by Application Studies." The Agency is taking this action in response to a request for an extension to allow interested pe...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-01350</p>
    <p><strong>Publication Date:</strong> 2018-01-26</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/01/26/2018-01350/recommendations-for-dual-510k-and-clinical-laboratory-improvement-amendments-waiver-by-application">https://www.federalregister.gov/documents/2018/01/26/2018-01350/recommendations-for-dual-510k-and-clinical-laboratory-improvement-amendments-waiver-by-application</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-01350</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
